These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34287247)

  • 1. Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan.
    Kimizu T; Ida S; Okamoto K; Awano H; Niba ETE; Wijaya YOS; Okazaki S; Shimomura H; Lee T; Tominaga K; Nabatame S; Saito T; Hamazaki T; Sakai N; Saito K; Shintaku H; Nozu K; Takeshima Y; Iijima K; Nishio H; Shinohara M
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34287247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment.
    Nigro E; Grunebaum E; Kamath B; Licht C; Malcolmson C; Jeewa A; Campbell C; McMillan H; Chakraborty P; Tarnopolsky M; Gonorazky H
    Front Neurol; 2023; 14():1230889. PubMed ID: 37780708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
    Kimizu T; Nozaki M; Okada Y; Sawada A; Morisaki M; Fujita H; Irie A; Matsuda K; Hasegawa Y; Nishi E; Okamoto N; Kawai M; Imai K; Suzuki Y; Wada K; Mitsuda N; Ida S
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal Muscular Atrophy.
    Oskoui M; Servais L
    Continuum (Minneap Minn); 2023 Oct; 29(5):1564-1584. PubMed ID: 37851043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry.
    Servais L; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Proud CM; Shieh PB; Tizzano EF; Quijano-Roy S; Desguerre I; Saito K; Faulkner E; Benguerba KM; Raju D; LaMarca N; Sun R; Anderson FA; Finkel RS
    J Neuromuscul Dis; 2024; 11(2):425-442. PubMed ID: 38250783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England.
    Weidlich D; Servais L; Kausar I; Howells R; Bischof M
    Neurol Ther; 2023 Aug; 12(4):1205-1220. PubMed ID: 37222861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.
    Armengol VD; Darras BT; Abulaban AA; Alshehri A; Barisic N; Ben-Omran T; Bernert G; Castiglioni C; Chien YH; Farrar MA; Kandawasvika G; Khadilkar S; Mah J; Marini-Bettolo C; Osredkar D; Pfeffer G; Piazzon FB; Pitarch Castellano I; Quijano-Roy S; Saito K; Shin JH; Vázquez-Costa JF; Walter MC; Wanigasinghe J; Xiong H; Griggs RC; Roy B
    Neurol Clin Pract; 2024 Feb; 14(1):e200224. PubMed ID: 38107546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onasemnogene Abeparvovec: Post-infusion Efficacy and Safety in Patients With Spinal Muscular Atrophy (SMA)-A Fondazione Policlinico Gemelli IRCCS Experience.
    Favia M; Tarantino D; Cerbo LD; Sabia A; Campopiano R; Pani M
    Hosp Pharm; 2024 Feb; 59(1):39-46. PubMed ID: 38223869
    [No Abstract]   [Full Text] [Related]  

  • 12. Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
    Schroth M; Deans J; Arya K; Castro D; De Vivo DC; Gibbons MA; Ionita C; Kuntz NL; Lakhotia A; Neil Knierbein E; Scoto M; Sejersen T; Servais L; Tian C; Waldrop MA; Vázquez-Costa JF
    Neurol Clin Pract; 2024 Aug; 14(4):e200310. PubMed ID: 38915908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal screening for spinal muscular atrophy: A pilot study in Brazil.
    Oliveira Netto AB; Brusius-Facchin AC; Lemos JF; Pasetto FB; Brasil CS; Trapp FB; Saute JAM; Donis KC; Becker MM; Wiest P; Coutinho VLS; Castro S; Ferreira J; Silveira C; Bittar MFR; Wang C; Lana JM; França Junior MC; Giugliani R
    Genet Mol Biol; 2023; 46(3 Suppl 1):e20230126. PubMed ID: 38091267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing datasets.
    Weisburd B; Sharma R; Pata V; Reimand T; Ganesh VS; Austin-Tse C; Osei-Owusu I; O'Heir E; O'Leary M; Pais L; Stafki SA; Daugherty AL; Folland C; Perić S; Fahmy N; Udd B; Horakova M; Łusakowska A; Manoj R; Nalini A; Karcagi V; Polavarapu K; Lochmüller H; Horvath R; Bönnemann CG; Donkervoort S; Haliloğlu G; Herguner O; Kang PB; Ravenscroft G; Laing N; Scott HS; Töpf A; Straub V; Pajusalu S; Õunap K; Tiao G; Rehm HL; O'Donnell-Luria A
    medRxiv; 2024 Jun; ():. PubMed ID: 38405995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical-Experimental, and Real-World Evidence.
    Crisafulli S; Boccanegra B; Vitturi G; Trifirò G; De Luca A
    Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey.
    Curry MA; Cruz RE; Belter LT; Schroth MK; Jarecki J
    Neurol Ther; 2024 Jun; 13(3):583-598. PubMed ID: 38430355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular based newborn screening in Germany: Follow-up for cystinosis.
    Hohenfellner K; Bergmann C; Fleige T; Janzen N; Burggraf S; Olgemöller B; Gahl WA; Czibere L; Froschauer S; Röschinger W; Vill K; Harms E; Nennstiel U
    Mol Genet Metab Rep; 2019 Dec; 21():100514. PubMed ID: 31641587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-diabetic Euglycemic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II.
    Khludenev G; Le Cam E; Ainapurapu BB
    Cureus; 2023 Sep; 15(9):e45666. PubMed ID: 37868546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy-based strategies for spinal muscular atrophy-an Asia-Pacific perspective.
    Farrar MA; Calotes-Castillo L; De Silva R; Barclay P; Attwood L; Cini J; Ferrie M; Kariyawasam DS
    Mol Cell Pediatr; 2023 Nov; 10(1):17. PubMed ID: 37964159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.